Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 02-2022 | 11-2021 | 08-2021 | 05-2021 | 02-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,116 | -47,918 | -9,477 | N/A | -29,799 |
| Depreciation Amortization | 46,545 | 10,959 | 5,054 | N/A | 14,808 |
| Income taxes - deferred | -5,471 | -4,963 | -2,138 | N/A | -7,307 |
| Accounts receivable | -7,525 | 4,541 | 7,997 | N/A | 6,345 |
| Accounts payable and accrued liabilities | 13,507 | 15,148 | 1,517 | N/A | 6,372 |
| Other Working Capital | -8,811 | 4,238 | 6,858 | N/A | 9,212 |
| Other Operating Activity | 826 | 13,689 | -8,980 | 0 | 10,969 |
| Operating Cash Flow | $-22,045 | $-4,306 | $831 | $N/A | $10,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17,443 | -11,928 | -6,831 | N/A | 1,502 |
| Net Acquisitions | 73,500 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 45,100 | 45,100 | 45,100 | N/A | N/A |
| Other Investing Activity | -2,390 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $98,767 | $33,172 | $38,269 | $N/A | $1,502 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 45,011 | 26,000 | 8,000 | N/A | 83,000 |
| Debt Issued | N/A | N/A | N/A | N/A | 150,000 |
| Debt Repayment | -86,376 | -41,426 | -41,388 | N/A | -114,095 |
| Other Financing Activity | -34,798 | -13,644 | -5,560 | 0 | -129,312 |
| Financing Cash Flow | $-76,163 | $-29,070 | $-38,948 | $N/A | $-10,407 |
| Beginning Cash Position | 1,295 | 1,295 | 1,295 | N/A | 553 |
| End Cash Position | 1,854 | 1,091 | 1,447 | N/A | 2,248 |
| Net Cash Flow | $559 | $-204 | $152 | $N/A | $1,695 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,045 | -4,306 | 831 | N/A | 10,600 |
| Capital Expenditure | -18,539 | -13,010 | -7,913 | N/A | -11,383 |
| Free Cash Flow | -40,584 | -17,316 | -7,082 | 0 | -783 |